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Case Report
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Caroli’s Disease (CD) is a rare congenital disorder
characterized by cystic dilatation of the intrahepatic
bile ducts. This report describes a patient with cho-
langiocarcinoma arising in the setting of monolobar
CD. In spite of detailed investigations including
biliary enteric bypass and endoscopic retrograde
cholangiography, the diagnosis of mucinous cholan-
giocarcinoma (CCA) was not made for almost one
year. The presentation, diagnosis and treatment of
monolobar CD and the association between mono-
lobar CD and biliary tract cancer are discussed.
Hepatic resection is the treatment of choice for
monolobar CD.
Keywords: Caroli’s disease, cholangiocarcinoma, biliary cys-
tic disease
INTRODUCTION
Caroli’s Disease(CD) is a rare congenital condi-
tion characterized by diffuse or focal cystic
dilatation of the intrahepatic bile ducts [1]. Two
forms are described, a simple type in which bile
ducts are dilated and cystic, without hepatic fi-
brosis or its sequelae. The second type is assoc-
iated with peri-portal fibrosis and leads to portal
hypertension, esophageal varices and sometimes
liver failure. Both types are characterized by
recurrent episodes of intrahepatic biliary lithiasis
and cholangitis as well as increased risk for
development of biliary tract cancer. In some
patients, the disease is confined within one
hepatic lobe, with less than 150 cases of mono-
lobar CD reported in the literature [2, 3].
The etiology of CD is unclear, but it has been
postulated that prenatal vascular accident leads
to stricture and dilatation of bile ducts [1]. Liver
resection, biliary bypass, endoscopic or percuta-
neous drainage, alone or in combination, have all
been used to treat CD [4-6].
This report describes a patient with CD con-
fined to the left liver, who developed recurrent
cholangitis after biliary enteric bypass and
required left lobectomy. At the time of lobect-
omy, the patient was found to have metastatic,
low-grade nucinous cholangiocarcinoma. The
presentation, diagnosis and treatment of mono-
*Corresponding author. Tel.: (713) 792-2022, Fax: (713) 792-0722, e-mail: jvauthey@notes.mdacc.tmc.edu
271
272 E.K. ABDALLA et al.
lobar CD and the association between mono-
lobar CD and biliary tract cancer is discussed.
CASE REPORT
A 73-year-old man was referred with recurrent
cholangitis four weeks following laparoscopic
cholecystectomy. Intraoperative cholangiogram
had demonstrated multiple hepatic duct defects
and left intrahepatic duct dilatation. Physical ex-
amination was unremarkable at the time of refer-
ral, and laboratory data were as follows: total
bilirubin 2.1 mg/dl, direct bilirubin 1.1 mg/dl,
AST 126 U/1 ALT 111 U/I, alkaline phosphatase
648 U/I, WBC 15,000/mm3. Abdominal ultra-
sound confirmed persistent intrahepatic bile duct
dilatation and common bile duct obstruction, but
no liver mass.
Surgical exploration revealed a normal appear-
ing liver with a remnant of the gallbladder
infundibulum and long cystic duct with an in-
flammatory node obstructing the common bile
duct. There was no hepatic mass palpable or
identified by intraoperative ultrasound. Intrao-
perative choledochoscopy showed mild ductal
inflammation and a single left intrahepatic stone,
which was extracted. Frozen and permanent
sections of the common hepatic duct and liver
parenchyma revealed no tumor or cirrhosis. End-
to-side hepaticoduodenostomy was performed to
provide adequate drainage and retain endoscopic
access to the biliary tree. The patient was
discharged after five days.
The patient returned within one year with
recurrent cholangitis. Biliary scan revealed nor-
mal excretion of the right lobe of the liver with
delayed excretion of the left liver. Computed
tomography scan demonstrated persistent multi-
focal dilatation confined to the left bile duct
system without mass (Fig. 1). Endoscopic retro-
grade cholangiography showed cystic dilatation
of the left bile duct system without evidence of
obstruction and a normal right biliary tree. The
choledochoduodenostomy was patent. Brushing
FIGURE CT scan of the abdomen reveals dilated left
biliary system, normal right biliary system and no evidence
of a mass or tumor.
cytology was negative. Magnetic resonance cho-
langiography confirmed patent intra-and extra-
hepatic bile ducts with ductal dilatation confined
to the left liver. Given the persistent cholangitis
and that disease was confined to a single hepatic
lobe, left lobectomy was indicated.
At operation, sheets of mucinous tumor were
found, though restricted to the dome of the liver
and right hemidiaphragm. Frozen section re-
vealed low-grade adenocarcinoma. There was
no other implant or lymphadenopathy found
upon further exploration of the abdomen. A
palliative left hepatic lobectomy was performed.
Given the low-grade nature of the neoplasm, the
peritoneum of the right diaphragm and the
hepatic capsular implants were resected to
debulk all gross disease. The post-operative
course was unremarkable but for a mild pneu-
monia which had resolved at discharge on the
ninth post-operative day.
On examination of the resected specimen, the
hepatic capsule was unremarkable while coronal
sections revealed gross ectasia of the left bile duct
system without definite obstruction by stone or
tumor mass. The ducts were filled with mucin
and their walls were thickened. The surrounding
hepatic parenchyma was grossly unremarkable.
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FIGURE 2 Large panel: Low power (1.5X) view of hepatic
hilum demonstrating distended bile ducts with prominent
papillary lining epithelium. Inserts demonstrate the two
observed histologic patterns. Upper insert: Short papillae with
marked architectural and cytologic atypia (125X). Lower
insert: Taller, well-differentiated papillae with minimal
nuclear atypia (125X).
Histopathology revealed diffuse involvement
of the bile duct by a well-differentiated papillary
mucinous cholangiocarcinoma (Fig. 2). The neo-
plastic epithelium displayed increased nuclear/
cytoplasmic ratio, nuclear hyperchromasia and
cigar shaped, tightly packed nuclei. The cyto-
plasm was filled with mucin and architecturally
ranged from flat to papillary. In spite of
exhaustive sampling of the specimen, no infil-
trative neoplasm was identified. The peritoneal
implants were composed of small strips of low-
grade epithelium in large pools of mucin.
DISCUSSION
In 1958, Caroli and Couinaud characterized
congenital intrahepatic biliary cystic disease [1].
Later, Barros’ review of the literature confirmed
two basic types, one which manifests simply with
cystic intrahepatic bile ducts, and another asso-
ciated with hepatic fibrosis [2]. Since then more
than 300 cases of CD have been reported, with 137
confined to a single hepatic lobe [3, 6, 7-17].
The pathophysiology of the disease is un-
known, though Caroli postulated that it is
congenitally acquired [1]. Doppman suggested
that prenatal hepatic vascular accident may lead
to bile duct stricture and subsequent dilatation
[19]. Reports of CD in twin sisters and in families
suggest that this disease is inherited [20]. When
CD is associated with congenital hepatic fibrosis,
it is transmitted as an autosomal recessive
disorder [21]. Cholangitis, bile stasis and intrahe-
patic stone formation are common features of the
disease as illustrated in the patient reported.
Septicemia, intrahepatic and subphrenic abscess
can follow. In the case presented, a single
intrahepatic stone was extracted at the time of
biliary bypass but cholangitis and bile duct
dilatation persisted. The disease usually involves
the entire liver but may be restricted to a single
lobe or segment. In monolobar CD, the left liver is
most commonly affected with a 3:1 left lobe
predominance [5]. The reason for this predomi-
nant distribution is unknown.
Symptoms occur after 5 to more than 60 years
of life. The first episode of bacterial cholangitis
is usually spontaneous, and the main (and often
only) symptom is unexplained fever without pain
or jaundice. If associated with congenital hepatic
fibrosis, manifestations of portal hypertension
may dominate the clinical presentation. Liver
function tests are normal except for moderately
elevated alkaline phosphatase and gamma gluta-
myltranspeptidase [5].
Ultrasound or computed tomography are often
the first studies to demonstrate an abnormally
dilated biliary system. Cholangiography (percu-
taneous or endoscopic) defines the biliary anat-
omy. Hepatobiliary scintigraphy evaluates
function. In the patient presented it documented
intact biliary excretion of the right lobe.
The most serious complication of CD is the
development of biliary tract cancer. Dayton
reported cancer in 10 of 142 patients with CD
(7%) [6]. Similarly, Guntz, in 1991, found eight
cases of malignant degeneration in 104 patients
with monolobar CD (7%) [3]. Our review of the
literature (Tab. I) revealed 13 cases of carcinoma
in 137 cases of monolobar CD (11%). Eight were
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TABLE Reported cases of monolobar CD and biliary tract cancer
Left Monolobar Caroli’s Disease and Carcinoma (8 cases)
Author Year Age/sex Histologic type Treatment Outcome
Todani [42] 1978 26/F Metastatic
cholangiocarcinoma
Chen [43 1981 72/M Cholangiocarcinoma
Leroy [44] 1982 51/F Papillary mucoid
cholangiocarcinoma
Roudot-Thoraval [45] 1982 49/F Papillary
cholangiocarcinoma
Chevillotte 46] 1984 48/M Papillary
cholangiocarcinoma
Guntz [21] 1987 62/F Gallbladder
adenocarcinoma in situ
Joly [47] 1990 74/M Cholangiocarcinoma in situ
Present case 1997 73/M Papillary mucinous
cholangiocarcinoma
Right Monolobar Caroli’s Disease and Carcinoma (5 cases)
Author Year Age/sex Histologic type
Excision and Died 48 days
hepatico- after operation
jejunostomy
Left lobectomy Not reported
Left lobectomy Not reported
Left lobectomy Not reported
Left lobectomy Died
and hepaticojeju- 16 months
nostomy after operation
Cholecystect- Disease free
omy and at 58 months
hepaticojeju-
nostomy
Left lobectomy Not reported
Left lobectomy, Symptom free
peritoneumect- at 10 months
omy
Treatment Outcome
Phinney [48] 1981 57/M Poorly to moderately
well-differentiated
cholangiocarcinoma
Dayton (case 4) [6] 1983 59/M Invasive
cholangiocarcinoma
Rossi [28] 1987 64/M Invasive
cholangiocarcinoma
Horie [49] 1987 40/M Papillary
cholangiocarcinoma
Falco 17] 1993 68/M Papillary mucinous
cholangiocarcinoma
Choledochojej- Died in post-
unostomy x 2 operative
period
Choledochoje- Died at
junostomy month
Transhepatic Died at
stenting 4 months
Right partial Symptom free
lobectomy, at 3.5 years
cholecystectomy
Hepaticoenter- Died at
ostomy 13 months
located on the left side and five on the right. All
were cholangiocarcinomas except for one case of
gallbladder carcinoma [21]. Similar to the case
presented, the majority of the patients were men
older than 50 suggesting longstanding subclinical
disease before the onset of cancer.
The increased risk of cholangiocarcinoma in
CD is also found in cystic disease of the extra-
hepatic bile ducts and oriental hepatolithiasis
[22-24]. Cholangiocarcinoma develops in 2.5-
28% of bile duct cysts [25-32], whereas the
incidence of biliary carcinoma in the absence of
biliary cystic disease is only 0.0007-0.014% [25].
The reason for this association remains unknown
but bile stasis and chronic cholangitis are con-
sidered to be risk factors [26, 33].
The diagnosis of cancer in the setting of CD is
difficult. Endoscopic biopsy, with brushing and
washing yields a diagnosis in less than half of
cases of bile duct cancers. The overall sensitivity
of preoperative cytology is 42% or less [34- 37]. A
mass is infrequently identified. Surgical explora-
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tion with frozen and permanent sections is
frequently non-diagnostic [6].
The extent of intrahepatic disease and the
presence of fibrosis or cirrhosis should guide the
treatment of CD. When the disease is localized,
resection is the mainstay of treatment [3, 20, 25,
38]. Biliary bypass, whether by choledochoduo-
denostomy or Roux-en-Y choledochojejunost-
omy, cannot circumvent the development of
hepatolithiasis, recurrent cholangitis, or the risk
of cancer [25-29, 38-40]. In the patient pre-
sented, the cholangiocarcinoma was a non-inva-
sive, yet aggressive, mucinous tumor which
implanted in the peritoneum of the right dia-
phragm and the capsule of the right lobe. This
seeding outside of the biliary tract was likely due
to the manipulation, including choledochoscopy,
performed at the time of biliary enteric bypass.
Reports persist in the recent literature suggest-
ing that localized disease might be treated pal-
liatively, endoscopically or surgically with biliary
enteric bypass, based on the premise that drai-
nage procedures avert the risk of cancer asso-
ciated with chronic infection and bile stasis [4].
This unfortunately ignores Todani’s finding that
57% of 63 cases of carcinoma in patients with all
types of biliary cystic disease had previously
undergone drainage procedures, and that cancer
was found from I to 32 years later [38].
Diffuse CD is a more difficult problem. Most
recommend a combination of resection and
internal bypass, endoscopic or percutaneous
stents, or even in rare cases, hepatic transplanta-
tion. Antibiotics and litholytic agents are adjuncts
[4, 5]. Prognosis for extensive bilateral disease and
CD associated with hepatic fibrosis is muchworse
than for limited disease.
In the patient presented, cholangiocarcinoma
remained undiagnosed in spite of bile duct ex-
ploration and cytology, and was found 10 months
following choledochoduodenostomy. The diag-
nosis of carcinoma is exceedingly difficult pre-
operatively and the prognosis is poor if the
diagnosis is delayed. In monolobar CD, hepatic
resection is the treatment of choice as it provides
definitive treatment and may contribute to an
early diagnosis of cancer. Non-surgical treatment
is the mainstay of management of diffuse disease.
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COMMENTARY
The authors are to be commended for their
prompt decision to resect the left lobe of the liver
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when the patient presented again with acute
cholangitis. Indeed, in a 70-year-old man with
isolated segmental or LOBAR dilatation of
intrahepatic duct, cholangiocarcinoma involving
the orifice of major branch of intra-hepatic duct
should be suspected until proven otherwise. The
rule applies to whatever etiology, be it an oriental
hepatolithiasis or western Caroli’s disease. A
good quality CT scan is preferable before com-
mon duct exploration, and biopsy of any suspi-
cious area in the ductal wall during
choledochoscopy must be encouraged. Serum
carcino-embryonic antigen may be elevated in
patients with cholangiocarcinoma and if shown to
be elevated will give a hint to the possible etiology
of isolated segmental dilatation. Performing a
bilio-enteric drainage atthe common duct level to
a ductal system which is dilated only on one side
is conceptually wrong because any drainage
operation distal to the probable site of obstruction
will certainly fail. Constructing a choledochoduo-
denostomy in the presence of intrahepatic seg-
mental dilatation will induce recurrent acute
cholangitis since food reflux into the intrahepatic
ductal system will not be able to egress freely back
to the duodenum.
Caroli’s disease is an uncommon condition.
The diagnosis may not be readily made when first
seen by a clinician but the principle of surgery for
segmental intrahepatic ductal dilatation should
be applicable to any etiology.
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